WO2006010077A3 - Promedicaments de lonidamine et analogues de lonidamine - Google Patents
Promedicaments de lonidamine et analogues de lonidamine Download PDFInfo
- Publication number
- WO2006010077A3 WO2006010077A3 PCT/US2005/024434 US2005024434W WO2006010077A3 WO 2006010077 A3 WO2006010077 A3 WO 2006010077A3 US 2005024434 W US2005024434 W US 2005024434W WO 2006010077 A3 WO2006010077 A3 WO 2006010077A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lonidamine
- prodrugs
- analogs
- methods
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne des promédicaments de lonidamine et des analogues de lonidamine, ainsi que des méthodes d'utilisation desdits promédicaments.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58693404P | 2004-07-08 | 2004-07-08 | |
| US60/586,934 | 2004-07-08 | ||
| US62450504P | 2004-11-01 | 2004-11-01 | |
| US60/624,505 | 2004-11-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2006010077A2 WO2006010077A2 (fr) | 2006-01-26 |
| WO2006010077A3 true WO2006010077A3 (fr) | 2006-08-31 |
Family
ID=35785776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2005/024434 Ceased WO2006010077A2 (fr) | 2004-07-08 | 2005-07-08 | Promedicaments de lonidamine et analogues de lonidamine |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2006010077A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016523926A (ja) | 2013-07-01 | 2016-08-12 | ユニバーシティ オブ ジョージア リサーチ ファンデーション，インコーポレーテッド | 抗癌療法のための細胞ミトコンドリアへの治療剤の正確な送達 |
| EP3564214B1 (fr) | 2018-05-04 | 2024-07-03 | Universita' Degli Studi G. D'annunzio Chieti - Pescara | Dérivés d'indazole en tant que modulateurs du système de cannabinoïdes |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3895026A (en) * | 1972-02-29 | 1975-07-15 | Acraf | Substituted 1-benzyl-1h-indazole-3-carboxylic acids and derivatives thereof |
| US5260327A (en) * | 1985-10-02 | 1993-11-09 | Sloan-Kettering Institute For Cancer Research | Methods for inhibiting the proliferation of brain and hepatic metastases by using lonidamine |
-
2005
- 2005-07-08 WO PCT/US2005/024434 patent/WO2006010077A2/fr not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3895026A (en) * | 1972-02-29 | 1975-07-15 | Acraf | Substituted 1-benzyl-1h-indazole-3-carboxylic acids and derivatives thereof |
| US5260327A (en) * | 1985-10-02 | 1993-11-09 | Sloan-Kettering Institute For Cancer Research | Methods for inhibiting the proliferation of brain and hepatic metastases by using lonidamine |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006010077A2 (fr) | 2006-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007133290A3 (fr) | Anticorps anti-ox40l et méthodes correspondantes | |
| MX286273B (es) | Composiciones y metodos para inhibicion de la via jak. | |
| WO2006023651A3 (fr) | Traitement prolonge de la sclerose en plaques | |
| ZA200605348B (en) | Solid forms of anti-EGFR-antibodies | |
| WO2005097825A3 (fr) | Variants de bmp-7 ayant des proprietes ameliorees | |
| WO2006119295A3 (fr) | Compositions et methodes de traitement de maladies neurodegeneratives | |
| WO2008013589A3 (fr) | Traitement de tumeurs exprimant ras | |
| WO2006124713A3 (fr) | 4-biarylyl-1-phenylazetidin-2-ones | |
| WO2007130697A8 (fr) | Anticorps anti-ephb4 et procedes qui les utilisent | |
| EP1641437A4 (fr) | Dispersion solide de tacrolimus | |
| WO2007127506A3 (fr) | Anticorps anti-ephrinb2 et procédés les utilisant | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| ZA200805711B (en) | Solid biocidal compositions and methods of using the same | |
| WO2008069976A3 (fr) | Composés et procédés pour imagerie et thérapie de tumeurs médiées par des enzymes | |
| WO2006015191A3 (fr) | Analogues de lonidamine multicycliques | |
| WO2006081337A3 (fr) | Erastine et proteines de liaison d'erastine, et utilisations de celles-ci | |
| WO2007117704A3 (fr) | Isomeres de tritoqualine purs | |
| WO2007022321A3 (fr) | Indoles substitues et procedes d'utilisation de ceux-ci | |
| WO2006010077A3 (fr) | Promedicaments de lonidamine et analogues de lonidamine | |
| WO2006095173A3 (fr) | Utilisation d'un compose | |
| GB0313630D0 (en) | Compositions for the enhanced treatment of depression | |
| WO2007064997A3 (fr) | Composes et procedes permettant d'inhiber l'apoptose | |
| WO2006031799A3 (fr) | Composition contenant des ubiquinones | |
| WO2006116687A3 (fr) | Nanodosages | |
| GB2418723B (en) | Description of the office mouse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| 122 | Ep: pct application non-entry in european phase |